Mills GB - Search Results

1

AKT pathway genes define 5 prognostic subgroups in glioblastoma.

Joy A, Ramesh A, Smirnov I, Reiser M, Misra A, Shapiro WR, Mills GB, Kim S, Feuerstein BG. Joy A, et al. Among authors: mills gb. PLoS One. 2014 Jul 1;9(7):e100827. doi: 10.1371/journal.pone.0100827. eCollection 2014. PLoS One. 2014. PMID: 24984002 Free PMC article.

2

Targeting the phosphatidylinositol 3-kinase/Akt pathway for enhancing breast cancer cells to radiotherapy.

Liang K, Jin W, Knuefermann C, Schmidt M, Mills GB, Ang KK, Milas L, Fan Z. Liang K, et al. Among authors: mills gb. Mol Cancer Ther. 2003 Apr;2(4):353-60. Mol Cancer Ther. 2003. PMID: 12700279

3

Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.

Lu Y, Yu Q, Liu JH, Zhang J, Wang H, Koul D, McMurray JS, Fang X, Yung WK, Siminovitch KA, Mills GB. Lu Y, et al. Among authors: mills gb. J Biol Chem. 2003 Oct 10;278(41):40057-66. doi: 10.1074/jbc.M303621200. Epub 2003 Jul 17. J Biol Chem. 2003. PMID: 12869565 Free article.

4

Targeting PI3K-AKT pathway for cancer therapy.

Lu Y, Wang H, Mills GB. Lu Y, et al. Among authors: mills gb. Rev Clin Exp Hematol. 2003 Jun;7(2):205-28. Rev Clin Exp Hematol. 2003. PMID: 14763163 Review.

5

Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signaling.

Le XF, Lammayot A, Gold D, Lu Y, Mao W, Chang T, Patel A, Mills GB, Bast RC Jr. Le XF, et al. Among authors: mills gb. J Biol Chem. 2005 Jan 21;280(3):2092-104. doi: 10.1074/jbc.M403080200. Epub 2004 Oct 25. J Biol Chem. 2005. PMID: 15504738 Free article.

6

The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells.

Mandal M, Kim S, Younes MN, Jasser SA, El-Naggar AK, Mills GB, Myers JN. Mandal M, et al. Among authors: mills gb. Br J Cancer. 2005 May 23;92(10):1899-905. doi: 10.1038/sj.bjc.6602595. Br J Cancer. 2005. PMID: 15870708 Free PMC article. Retracted.

7

Exploiting the PI3K/AKT pathway for cancer drug discovery.

Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Hennessy BT, et al. Among authors: mills gb. Nat Rev Drug Discov. 2005 Dec;4(12):988-1004. doi: 10.1038/nrd1902. Nat Rev Drug Discov. 2005. PMID: 16341064 Review.

8

Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma.

Koul D, Shen R, Bergh S, Sheng X, Shishodia S, Lafortune TA, Lu Y, de Groot JF, Mills GB, Yung WK. Koul D, et al. Among authors: mills gb. Mol Cancer Ther. 2006 Mar;5(3):637-44. doi: 10.1158/1535-7163.MCT-05-0453. Mol Cancer Ther. 2006. PMID: 16546978

9

Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy.

Fujiwara K, Iwado E, Mills GB, Sawaya R, Kondo S, Kondo Y. Fujiwara K, et al. Among authors: mills gb. Int J Oncol. 2007 Oct;31(4):753-60. Int J Oncol. 2007. PMID: 17786305

10

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.

Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo WL, Davies M, Carey M, Hu Z, Guan Y, Sahin A, Symmans WF, Pusztai L, Nolden LK, Horlings H, Berns K, Hung MC, van de Vijver MJ, Valero V, Gray JW, Bernards R, Mills GB, Hennessy BT. Stemke-Hale K, et al. Among authors: mills gb. Cancer Res. 2008 Aug 1;68(15):6084-91. doi: 10.1158/0008-5472.CAN-07-6854. Cancer Res. 2008. PMID: 18676830 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,137 results

Search Page